The Orphan Drug for Acanthamoeba Keratitis (ODAK) Trial: PHMB 0.08 % (Polihexanide) and Placebo versus PHMB 0.02 % and Propamidine 0.1 - Dart, J KG; Papa, V; Rama, P (Ophthalmology, 2024)